OPCH (75) HIMS (63) CHE (84) AVAH (65) ⌘ Pro Terminal →

LifeStance Health Group Inc. (LFST) — RQD Stock Rating Cockpit

$13.64 +1.83% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.66

LifeStance Health Group Inc. (LFST) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $5.21B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $13.66 (+0.14%)🧬 Cannibal Buyback (-0.68% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 7.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY • 52.2% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE-0.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LFST)Realized 20D OHLCV Swing Band: ±7.2%

Deterministic 5-Pillar Attribution (57/100 Composite)

🔍 WHY LFST SCORES 57/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (32% of score)

Altman Z-Score 4.84 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (18% of score)

SEC XBRL FY 2025 (10-K): 7.7% FCF Margin ($110.0M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning9/20 pts (-11 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$12.42-5.5% Next Q

Q2 (-2Q)

Grade C-$11.74+10.1% Next Q

Q3 (-1Q)

Grade C-$12.93+5.5% Next Q

Current

Grade D+$13.64-0.2% Hist 90D α

Trajectory: D (49) → D+ (57)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the LFST Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 57/100 (D+) score, LFST faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.48) or 200D SMA ($9.34) invalidates the momentum regime and cuts Target Base ($13.58) toward Bear Floor ($10.59).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $LFST• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “LFST Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 57%NO 43%Trade / Inspect Odds →

RSI-14 MOMENTUMBULLISH MOMENTUM

64.830 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

4.84>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

8 / 99-Pt Accounting

52-WEEK LASER RANGE99% OF RANGE

L: $5$13.64H: $14

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 10 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 19 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B-RQD 28 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bearish Warning on LFST

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (50)

1.2% ROIC with 42.0% gross margin and 2.11% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (90)

Altman-Z 4.84 and Piotroski 8/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (48)

19/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like LFST

✓Clean SEC annual filing review with no major hidden accounting time-bombs.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LFST)

✓Walkthrough of LFST's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

LFST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +80.18%📐 HORIZONTAL RANGE

2026-10-30O $13.64H $13.76L $13.27C $13.64VOL 2.30M

RES: $14.88SUP: $11.14SMA50: $12.48SMA200: $9.34

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

LFST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 LFST Butterfly Map → + Track LFST →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +13.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on LFST today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for LFST. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for LFST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LFST)

Health Care Rank #249 of 1016 ⚔️ OPCH vs LFST Full Matrix →

1. Head-to-Head Health Care Peer Comparison (LFST vs. OPCH, HIMS, CHE, AVAH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, LifeStance Health Group Inc. (LFST) ranks #249 by composite RQD confidence (57/100, grade D+) and #165 by equity capitalization ($5.21B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while CHE leads on capital efficiency and profitability with 23.4% ROIC and 32.5% gross margin. CHE currently holds the highest overall quantitative score in the immediate peer group at 84/100 (A-) compared with LFST at 57/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
LFST ACTIVE LifeStance Health Group Inc.	D+	57/100	—	—	1.2%	+1.83%	$5.21B	Benchmark Subject
OPCH Option Care Health Inc.	B	75/100	23.0x	19.3%	11.9%	+1.79%	$4.77B	/opch-vs-lfst →
HIMS Hims & Hers Health Inc.	C	63/100	53.9x	73.8%	8.4%	+1.19%	$6.92B	/hims-vs-lfst →
CHE Chemed Corp	A-	84/100	—	32.5%	23.4%	+1.61%	$7.08B	/che-vs-lfst →
AVAH Aveanna Healthcare Holdings Inc.	C	65/100	—	33.3%	15.7%	+1.53%	$2.89B	/avah-vs-lfst →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001845257

In its most recent audited fiscal period (FY2025, filed 2025-12-31), LifeStance Health Group Inc. (LFST) reported GAAP revenue of $1.42B (+13.9% vs. FY2024 revenue of $1.25B , and +34.9% cumulative change since FY2023) , GAAP net income of $9.7M, operating cash flow of $146.2M, and free cash flow of $110.0M (+28.4% YoY). On the balance sheet, LFST closed FY2025 with $2.20B in total assets against $265.9M in total debt (Altman Z-Score: 4.84, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.42B	$9.7M	$146.2M	$110.0M	$2.20B	$265.9M
FY2024 (FY)	2024-12-31	$1.25B	-$57.4M	$107.3M	$85.7M	$2.12B	$279.8M
FY2023 (FY)	2023-12-31	$1.06B	-$186.3M	-$16.9M	-$16.9M	—	—

3. LFST Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is LFST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, LifeStance Health Group Inc. (NASDAQ: LFST) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $13.64 (+1.83% 1D, market cap $5.21B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, LFST ranks #249 in composite RQD confidence.

How does LFST compare to OPCH and HIMS in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), LFST carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 1.2%. By comparison, OPCH (Option Care Health Inc.) holds a B grade (75/100 RQD, P/E 23.0x, ROIC 11.9%, cap $4.77B) and HIMS (Hims & Hers Health Inc.) posts a C grade (63/100 RQD, P/E 53.9x, ROIC 8.4%, cap $6.92B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while CHE leads on capital efficiency (23.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for LFST?

Per LFST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001845257), LifeStance Health Group Inc. generated $1.42B in revenue (+13.9% YoY), $9.7M in net income, and $110.0M in free cash flow against $2.20B in total assets and $265.9M in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is LFST trading relative to its 50-day, 200-day, and 52-week technical levels?

LFST last traded at $13.64 (+1.83% on volume of 2,470,474 shares), positioning the stock +9.29% above its 50-day simple moving average ($12.48) and +46.04% above its 200-day simple moving average ($9.34). Across its 52-week range of $4.77 to $13.76, LFST sits at the 98.7% percentile with a 14-day RSI of 64.8 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.2% ($12.66 to $14.62).

LFST Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell LFST stock right now?

LifeStance Health Group Inc. (LFST) currently earns a Roarable Rating of D+ (Sell — SELL) with 57/100 RQD Confidence. Stretched risk/reward at current multiples (1% return on capital) under elevated 10-year interest-rate pressure.

What is LFST's 12-month price target and RQD AI Jury consensus?

LFST's 12-month base price target is $13.58 (range $10.59 to $16.02), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: LFST RQD Cockpit LFST 12M Forecast LFST Earnings & Move LFST Dividends & DRIP LFST Insiders & 13F LFST Whale Options LFST Profit Sankey LFST News & Why